| 查看: 557 | 回复: 0 | |||
zqw徒弟铜虫 (小有名气)
|
[交流]
SCI论文投稿征集：主题 lncRNA in cancer。 IF : 1.35
|
|
Please review the Manuscript Submission Guidelines before submitting your paper. Click here to submit your paper. https://journals.sagepub.com/pag ... rs/incrna-in-cancer lncRNAs are a class of ncRNAs with a size range from 200 to more than one hundred thousand nucleotides. lncRNAs exert their function through interacting with DNA, RNA, and protein, and other biological macromolecules. For example, they can regulate genetic transcription and perform epigenetic modification by binding DNA to generate RNA–DNA triplex complex; they can bind to and regulate the stability, activity, location of proteins through affect their post-translational modification; they can also function as a ceRNA through sponging miRNAs. Cancer is the second-leading cause of death in the world. About 90 million people die of malignant tumors. Accumulating evidence showed that lncRNAs played vital regulatory roles in the tumorigenesis and progression of cancers. This Special Issue aims to demonstrate the roles of lncRNAs in the tumorigenesis and the progression of cancers, reveal the prognostic and diagnostic importance for cancers. Potential topics include, but are not limited to: Cancer metabolism Cell apoptosis Cancer metastasis Resistance or sensitization to chemotherapy and radiotherapy Cell-cycle dysregulation Submit your paper. Manuscript Deadline: 3 January 2020 |
回复此楼» 猜你喜欢
人气不行了
已经有10人回复
-
如果此刻你正在为国基感到焦虑，不妨来听听这首《基金之外》
已经有6人回复
-
我面上完蛋了
已经有10人回复
-
能否退出参与的面上项目解除限项
已经有24人回复
-
filecode，4个jtjc了
已经有17人回复
-
没有任何消息-是不是就凉了
已经有6人回复
-
2026国自然函评费到账
已经有19人回复
-
建议基金发布提前给出明确的时间点
已经有16人回复
-
今日不放榜？网传国自然预计 8 月 27 日可查结果
已经有21人回复
-
估计是周四
已经有4人回复
20